Proxima Therapeutics
closedRadiation delivery systems for the treatment of solid cancerous tumors.
Launch date
Employees
Market cap
-
Enterprise valuation
€145m (Public information from Feb 2005)
Alpharetta Georgia (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$17.0m | Series D | ||
$14.0m | Series E | ||
$160m Valuation: $160m | Acquisition | ||
| Total Funding | €28.2m | ||
Related Content
Recent News about Proxima Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.